NCT07151482View on ClinicalTrials.gov

Impact of Oral Supplementation With Bioactive Collagen Peptides and Other Functional Ingredients

Not yet recruitingOBSERVATIONAL
Enrollment

43

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

February 28, 2028

Conditions
Genitourinary Syndrome of Menopause
Interventions
DIETARY_SUPPLEMENT

Collagendep

The purpose of this study is to evaluate the improvement of quality of life, vulvovaginal atrophy (VVA) and of initial Urinary Incontinence (UI) in menopausal women with GSM symptoms following oral administration of a food supplement treatment containing 2.5 g of BCP® and other functional ingredients taken once daily over a period of 16 weeks.

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT07151482 - Impact of Oral Supplementation With Bioactive Collagen Peptides and Other Functional Ingredients | Biotech Hunter | Biotech Hunter